Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma

American Journal of Human Genetics

Volumn 61, Issue 3, 1997, Pages 556-570

  Bremner, Rod ^a,c,d   Du, Daisy Chan ^a   Connolly Wilson, Mary J ^f   Bridge, Peter ^f,g   Ahmad, K Farid ^a   Mostachfi, Homa ^b   Rushlow, Dianne ^e   Dunn, James M ^e   Gallie, Brenda L ^a,b,c  

^a Eye Research Institute of Canada   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e Visible Genetics Inc   (Canada)

^f Medical Genetics Program   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; APOPTOSIS; ARTICLE; CANCER RISK; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL PROLIFERATION; GENE DELETION; HUMAN; PENETRANCE; PRIORITY JOURNAL; RETINOBLASTOMA; TUMOR SUPPRESSOR GENE;

EID: 0030827081     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/515499     Document Type: Article

References (123)

1. Adnane J, Shao Z, Robbins PD (1995) The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J Biol Chem 270:8837-8843
2. Aguzzi A, Brandner S, Isenmann S, Steinbach JP, Sure U (1995) Transgenic and gene disruption techniques in the study of neurocarcinogenesis. Glia 15:348-364
3. An B, Jin JR, Lin P, Dou QP (1996) Failure to activate interleukin 1β-converting enzyme-like proteases and to cleave retinoblastoma protein in drug-resistant cells. FEBS Lett 399: 158-162
4. Barnes WM (1994) PCR amplification of up to 35-kb DNA with high fidelity and high yield from bacteriophage templates. Proc Natl Acad Sci USA 91:2216-2220
5. Bautista D, Emanuel JR, Granville C, Howard R, Costa J (1996) Identification of mutations in the Ki-ras gene in human retinoblastoma. Invest Ophthalmol Vis Sci 37:2313-2317
6. Benedict WF, Murphree AL, Banerjee A, Spina DA, Sparkes MC, Sparkes RS (1983) Evidence from a patient with the deletion form of retinoblastoma that the retinoblastoma gene is a recessive cancer gene. Science 219:973-975
7. Bia B, Cowell JK (1995) Independent constitutional germline mutations occurring in the RB1 gene in cousins with bilateral retinoblastoma. Oncogene 11:977-979
8. Blanquet V, Turleau C, Gross MS, Goossens M, Besmond C (1993) Identification of germline mutations in the RB1 gene by denaturant gradient gel electrophoresis and polymerase chain reaction direct sequencing. Hum Mol Genet 2:975-979
9. Bookstein R, Shew JY, Chen PL, Scully P, Lee WH (1990) Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247:712-715
10. Bremner R, Cohen BL, Sopta M, Hamel PA, Ingles CJ, Gallie BL, Philips RA (1995) Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol Cell Biol 15: 3256-3265
11. Buchkovich K, Duffy LA, Harlow E (1989) The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105
12. Canning S, Dryja TP (1989) Short, direct repeats at the breakpoints of deletions of the retinoblastoma gene. Proc Natl Acad Sci USA 86:5044-5048
13. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, et al (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779-784
14. Chen PL, Scully P, Shew JY, Wang JY, Lee W-H (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193-1198
15. Chen WD, Otterson GA, Lipkowitz S, Khleif SN, Coxon AB, Kaye FJ (1997) Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene 14:1243-1248
16. Cheng S, Fockler C, Barnes WM, Higuchi R (1994) Effective amplification of long targets from cloned inserts and human genomic DNA. Proc Natl Acad Sci USA 91:5695-5699
17. Connolly MJ, Payne RH, Johnson G, Gallie BL, Allderdice PW, Marshall WH, Lawton RD (1983) Familial, EsD-linked, retinoblastoma with reduced penetrance and variable expressivity. Hum Genet 65:122-124
18. Cordon-Cardo C, Latres E, Drobjnak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, et al (1994) Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54:794-799
19. Cowell JK, Bia B, Akoulitchev A (1996) A novel mutation in the promotor region in a family with a mild form of retinoblastoma indicates the location of a new regulatory domain for the RB1 gene. Oncogene 12:431-436
20. Cowell JK, Smith T, Bia B (1994) Frequent constitutional C to T mutations in CGA-arginine codons in the RB1 gene produce premature stop codons in patients with bilateral (hereditary) retinoblastoma. Eur J Hum Genet 2:281-290
21. DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, et al (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-283
22. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM, et al (1989) The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095
23. Defeo-Jones D, Hunang PS, Jones RE, Haskell KM, Vuocolo GA, Hanobik MG, Huber HE, et al (1991) Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 352:251-254
24. DeGregori JT, Kowalik T, Nevins JR (1995) Cellular targets for activation by the E2F1 transcription factor include DNA synthesis and G1/S regulatory genes. Mol Cell Biol 15: 4215-4224
25. de Oca Luna RM, Tabor AD, Eberspaecher H, Hulboy DL, Worth LL, Colman MS, Finlay CA, et al (1996) The organization and expression of the mdm2 gene. Genomics 33:352-357
26. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA (1993) Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511
27. Draper GJ, Sanders BM, Kingston JE (1986) Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53: 661-671
28. Dryja TP, Rapaport J, McGee TL, Nork TM, Schwartz TL (1993) Molecular etiology of low-penetrance retinoblastoma in two pedigrees. Am J Hum Genet 52:1122-1128
29. Dunn JM, Phillips RA, Zhu X, Becker AJ, Gallie BL (1989) Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol 9:4596-4604
30. Duronio RJ, O'Farrell PH (1995) Developmental control of the G1 to S transition in Drosophila: cyclin E is a limiting downstream target of E2F. Genes Dev 9:1456-1468
31. Dyson N, Howley PM, Münger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937
32. Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, et al (1993) Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 85:1121-1128
33. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497
34. Ewen ME, Xing Y, Lawrence JB, Livingston DM (1991) Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-1164
35. Fakharzadeh SS, Trusko SP, George DL (1991) Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 10:1565-1569
36. Finlay CA (1993) The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol Cell Biol 13:301-306
37. Flemington EK, Speck SH, Kaelin W Jr (1993) E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 90:6914-6918
38. Gallie BL, Ellsworth RM, Abramson DH, Phillips RA (1982a) Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer 45:513-521
39. Gallie BL, Hei Y-J, Dunn JM (1995) Retinoblastoma: for the next generation. In: Cowell J (ed) Cancer genetics. Bios Scientific, London, pp 1-29
40. Gallie BL, Phillips RA, Ellsworth RM, Abramson DH (1982b) Significance of retinoma and phthisis bulbi for retinoblastoma. Ophthalmology 89:1393-1399
41. Gallie BL, Wong JJ, Ellsworth RM, Dupont B, Good RA (1979) Immunological mechanisms in spontaneous regression of retinoblastoma. In: Silverstein AM, O'Connor GR (eds) Immunology and immunopathology of the eye. Masson, New York, pp 190-196
42. Goddard AD, Balakier H, Canton M, Dunn J, Squire J, Reyes E, Becker A, et al (1988) Infrequent genomic rearrangement and normal expression of the putative RB1 gene in retinoblastoma tumors. Mol Cell Biol 8:2082-2088
43. Goodrich DW, Wang NP, Qian YW, Lee EYHP, Lee WH (1991) The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293-302
44. Group MS (1992) Diagnosis of Duchenne and Becker muscular dystrophies by polymerase chain reaction. JAMA 267: 2609-2615
45. Hagemeier C, Bannister AJ, Cook A, Kouzarides T (1993a) The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci USA 90:1580-1584
46. Hagemeier C, Cook A, Kouzarides T (1993b) The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res 21:4998-5004
47. Hamel PA, Cohen BL, Sorce LM, Gallie BL, Phillips RA (1990) Hyperphosphorylation of the retinoblastoma gene product is determined by domains outside the Simian virus 40 large-T-binding-regions. Mol Cell Biol 10:6586-6595
48. Hamel PA, Gill RM, Phillips RA, Gallie BL (1992) Transcriptional repression of the E2-containing promoters EIIaE, c-myc and RB1 by the product of the RB1 gene. Mol Cell Biol 12:3431-3438
49. Hannon GJ, Demetrick D, Beach D (1993) Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7:2378-2391
50. Hansen MF, Morgan R, Sandberg AA, Cavenee WK (1990) Structural alterations at the putative retinoblastoma locus in some human leukemias and preleukemia. Cancer Genet Cytogenet 49:15-23
51. Harbour JW, Lai SL, Whang PJ, Gazdar AF, Minna JD, Kaye FJ (1988) Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241:353-357
52. Harrison DJ, Hooper ML, Armstrong JF, Clarke AR (1995) Effects of heterozygosity for the Rb-1t19neo allele in the mouse. Oncogene 10:1615-1620
53. Hashimoto T, Takahashi R, Yandell DW, Xu HJ, Hu SX, Gunnell S, Benedict WF (1991) Characterization of intragenic deletions in two sporadic germinal mutation cases of retinoblastoma resulting in abnormal gene expression. Oncogene 6:463-469
54. Helin K, Harlow E, Fattaey A (1993) Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 13:6501-6508
55. Herrman J (1976) Delayed mutation as a cause of retinoblastoma: application to genetic counselling. Birth Defects 12: 79-90
56. Hiebert SW (1993) Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol 13:3384-3391
57. Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR (1992) The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6:177-185
58. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006
59. Hogg A, Bia B, Onadim Z, Cowell JK (1993) Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma. Proc Natl Acad Sci USA 90:7351-7355
60. Horowitz JM, Park S-H, Bogenmann E, Cheng J-C, Yandell DW, Kaye FJ, Minna JD, et al (1990) Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci USA 87:2775-2779
61. Horowitz JM, Yandell DW, Park S-H, Canning S, Whyte P, Buchkovich K, Harlow E, et al (1989) Point mutational inactivation of the retinoblastoma antioncogene. Science 243:936-940
62. Hu N, Gutsmann A, Herbert DC, Bradley A, Lee W-H, Lee EY-HP (1994) Heterozygous Rb-1D20/+ mice are predisposed to tumors of the pituitary gland with nearly complete penetrance. Oncogene 9:1021-1027
63. Hu QJ, Dyson N, Harlow E (1990) The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J 9:1147-1155
64. Huang S, Lee W-H, Lee EY-HP (1991) A cellular protein that completes with SV40 T antigen for binding to the retinoblastoma gene product. Nature 350:160-162
65. Ioannou P, Christopoulos G, Panayides K, Kleanthous M, Middleton L (1992) Detection of Duchenne and Becker muscular dystrophy carriers by quantitative multiplex polymerase chain reaction analysis. Neurology 42:1783-1790
66. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359:295-300
67. Janicke RU, Walker PA, Lin XY, Porter AG (1996) Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 15:6969-6978
68. Kato G, Wakabayashi K (1988) Effect of polylysine-bound Iaminin on human retinoblastoma cell lines. In Vitro Cell Dev Biol 24:274-280
69. Kato MV, Ishizaki K, Toguchida J, Kaneko A, Takayama J, Tanooka H, Kato T, et al (1994) Mutations in the retinoblastoma gene and their expression in somatic and tumor cells of patients with hereditary retinoblastoma. Hum Mutat 3:44-51
70. Kaye FJ, Kratzke RA, Getster JL, Horowitz JM (1990) A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci USA 87:6922-6926
71. Knudson AGJ (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823
72. Kratzke RA, Otterson GA, Hogg A, Coxon AB, Geradts J, Cowell JK, Kaye FJ (1994) Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. Oncogene 9: 1321-1326
73. Kratzke RA, Otterson GA, Lin AY, Shimizu E, Alexandrova N, Zajac-Kaye M, Horowitz JM, et al (1992) Functional analysis at the Cys706 residue of the retinoblastoma protein. J Biol Chem 267:25998-26003
74. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH (1993) MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 53:16-18
75. La Thangue NB (1994) DRTF1/E2F: an expanding family of heterodimeric transcription factors impicated in cell cycle control. Trends Biochem Sci 19:108-114
76. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, et al (1993) p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53:2231-2234
77. Lee EYHP, Chang CY, Hu N, Wang YCJ, Lai CC, Herrup K, Lee WH, et al (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-294
78. Li Y, Graham C, Lacy S, Duncan AMV, Whyte P (1993) The adenovirus E1A-associated 130kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7:2366-2377
79. Lohmann DR, Brandt B, Hopping W, Passarge E, Horsthemke B (1994) Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum Genet 94:349-354
80. Lohmann D, Horsthemke B, Gillessen KG, Stefani FH, Hofler H (1992) Detection of small RB1 gene deletions in retinoblastoma by multiplex PCR and high-resolution gel electrophoresis. Hum Genet 89:49-53
81. Lundgren K, de Oca Luna RM, McNeill YB, Emerick EP, Spencer B, Barfield CR, Lozano G, et al (1997) Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. Genes Dev 11:714-725
82. Maandag ECR, Van der Valk M, Vlaar M, Feltkamp C, O'Brien J, Van Roon M, Van der Lugt N, et al (1994) Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J 13: 4260-4268
83. Macklin MT (1960) A study of retinoblastoma in Ohio. Am J Hum Genet 12:1-43
84. Matsunaga E (1978) Hereditary retinoblastoma: delayed mutation or host resistance. Am J Hum Genet 30:406-424
85. Mayol X, Grana X, Baldi A, Sang N, Hu Q, Giordano A (1993) Cloning of a new member of the retinoblastoma gene family (pRB2) which binds to the E1A transforming domain. Oncogene 8:2561-2566
86. McFall RC, Sery TW, Makadon M (1977) Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res 37:1003-1010
87. Munier F, Spence MA, Pescia G, Balmer A, Gailloud C, Thonney F, Van Melle G, et al (1992) Paternal selection favoring mutant alleles of the retinoblastoma susceptibility gene. Hum Genet 89:508-512
88. Munier FL, Wang MX, Spence MA, Thonney F, Balmer A, Pescia G, Donoso LA, et al (1993) Pseudo low penetrance in retinoblastoma: fortuitous familial aggregation of sporadic cases caused by independently derived mutations in two large pedigrees. Arch Ophthalmol 111:1507-1511
89. Noorani HZ, Khan HN, Gallie BL, Detsky AS (1996) Cost comparison of molecular versus coventional screening of relatives at risk for retinoblastoma. Am J Hum Genet 59: 301-307
90. Ohtani K, Nevins JR (1995) Regulation of the cyclin E gene by the E2F transcription factor. Proc Natl Acad Sci USA 92:12146-12150
91. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83
92. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362: 857-860
93. Onadim Z, Hogg A, Baird PN, Cowell JK (1992) Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. Proc Natl Acad Sci USA 89: 6177-6181
94. Onadim Z, Hykin PG, Hungerford JL, Cowell JK (1991) Genetic counselling in retinoblastoma: importance of ocular fundus examination of first degree relatives and linkage analysis. Br J Ophthalmol 75:147-150
95. Onadim ZO, Mitchell CD, Rutland PC, Buckle BG, Jay M, Hungerford JL, Harper K, et al (1990) Application of intragenic DNA probes in prenatal screening for retinoblastoma gene carriers in the United Kingdom. Arch Dis Child 65: 651-656
96. Qian Y, Luckey C, Horton L, Esser M, Templeton DJ (1992) Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol Cell Biol 12:5363-5372
97. Qin XQ, Chittenden T, Livingston DM, Kaelin WGJ (1992) Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev 6:953-964
98. Reifenberger G, Liu L, Ichimura K, Scmidt EE, Collins VP (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736-2739
99. Sakai T, Ohtani N, McGee TL, Robbins PD, Dryja TP (1991) Oncogenic germ-line mutation of Sp1 and ATF sites in the human retinoblastoma gene. Nature 353:83-86
100. Scheffner M, Munger K, Byrne JC, Howley PM (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88:5523-5527
101. Schneider JW, Gu W, Zhu L, Mahdavi V, Nadal-Ginards B (1994) Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science 264:1467-1471
102. Schwartz LS, Tarleton J, Popovich B, Seltzer WK, Hoffman EP (1992) Fluorescent multiplex linkage analysis and carrier detection for Duchenne/Becker muscular dystrophy. Am J Hum Genet 51:721-729
103. Sellers WR, Rodgers JW, Kaelin WG Jr (1995) A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc Natl Acad Sci USA 92:11544-11548
104. Shew J-Y, Lin BT-Y, Chen P-L, Tseng BY, Yang-Feng TL, Lee WH (1990) C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc Natl Acad Sci USA 87:6-10
105. Squire J, Phillips RA, Boyce S, Godbout R, Rogers B, Gallie BL (1984) Isochromosome 6p, a unique chromosomal abnormality in retinoblastoma: verification by standard staining techniques, new densitometric methods, and somatic cell hybridization. Hum Genet 66:46-53
106. Stirdivant SM, Ahern JD, Oliff A, Heimbrook DC (1992) Retinoblastoma protein binding properties are dependent on 4 cysteine residues in the protein binding pocket. J Biol Chem 267:14846-14851
107. Strong LC, Riccardi VM, Ferrell RE, Sparkes RS (1981) Familial retinoblastoma and chromosome 13 deletion transmitted via an insertional translocation. Science 213:1501-1503
108. Tan X, Martin SJ, Green DR, Wang JYJ (1997) Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J Biol Chem 272:9613-9616
109. Templeton DJ, Park SH, Lanier L, Weinberg RA (1991) Non-functional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci USA 88:3033-3037
110. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y, Yamamuro T (1994) Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54: 3042-3048
111. Wang CY, Petryniak B, Thompson CB, Kaelin WG, Leiden JM (1993) Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science 260: 1330-1335
112. Welch PJ, Wang JYJ (1993) A c-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-abl tyrosine kinase in the cell cycle. Cell 75:779-790
113. _ (1995a) Abrogation of retinoblastoma function by c-Abl through tyrosine kinase-dependent and -independent mechanisms. Mol Cell Biol 15:5542-5551
114. _ (1995b) Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev 9:31-46
115. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E (1988) Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334: 124-129
116. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T (1994) Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7:480-484
117. Xiao Z-X, Chen J, Levine A, Modjtahedi N, Xing J, Sellers WR, Livingston DM (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375: 694-698
118. Yandell DW, Campbell TA, Dayton SH, Petersen R, Walton D, Little JB, McConkie RA, et al (1989) Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Engl J Med 321:1689-1695
119. Yokota J, Akiyama T, Fung YK, Benedict WF, Namba Y, Hanaoka M, Wada M, et al (1988) Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene 3:471-475
120. Zacksenhaus E, Bremner R, Phillips RA, Gallie BL (1993) A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. Mol Cell Biol 13:4588-4599
121. Zacksenhaus E, Jiang Z, Hei YJ, Phillips RA, Gallie BL (1996) Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product. EMBO J 15:5917-5927
122. Zhu L, Van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N, et al (1993) Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7:1111-1125
123. Zhu XP, Dunn JM, Phillips RA, Goddard AD, Paton KE, Becker A, Gallie BL (1989) Preferential germ line mutation of the paternal allele in retinoblastoma. Nature 340:312-313